Trulieve Cannabis (TSE:TRU – Get Free Report) was upgraded by analysts at Craig Hallum to a “strong-buy” rating in a report released on Wednesday,Zacks.com reports.
Separately, Atb Cap Markets raised shares of Trulieve Cannabis from a “hold” rating to a “strong-buy” rating in a research report on Monday, December 9th.
Get Our Latest Stock Report on Trulieve Cannabis
Trulieve Cannabis Price Performance
Insider Transactions at Trulieve Cannabis
About Trulieve Cannabis
TransUnion provides risk and information solutions. The company operates in three segments: U.S. Markets, International, and Consumer Interactive. The U.S. Markets segment provides consumer reports, actionable insights, and analytics to businesses. These businesses use its services to acquire new customers; assess consumer ability to pay for services; identify cross-selling opportunities; measure and manage debt portfolio risk; collect debt; verify consumer identities; and mitigate fraud risk.
Recommended Stories
- Five stocks we like better than Trulieve Cannabis
- Retail Stocks Investing, Explained
- Salesforce’s Hidden Strengths Could Fuel a Powerful Rebound
- How to Choose Top Rated Stocks
- 3 Stocks With Unusual Call Option Volume – What It Signals
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Top 4 Healthcare REITs Turning Care Into Big Investor Payouts
Receive News & Ratings for Trulieve Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trulieve Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.